Are you Dr. Boyd?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 SW 10th Ave
Topeka, KS 66604Phone+1 785-354-6000Fax+1 252-847-8368
Summary
- Dr. Jonathan Boyd, MD is a board certified pathologist in Topeka, Kansas. He is currently licensed to practice medicine in Kansas, Texas, and North Carolina. He is affiliated with Stormont Vail Health.
Education & Training
- Methodist Hospital (Houston)Fellowship, Hematopathology, 2014 - 2016
- ECU Health Medical Center/East Carolina UniversityResidency, Pathology-Anatomic and Clinical, 2010 - 2014
- University of Texas Southwestern Medical SchoolClass of 2010
Certifications & Licensure
- KS State Medical License 2017 - 2025
- TX State Medical License 2014 - 2022
- NC State Medical License 2010 - 2014
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 11 citationsTreatment of refractory hypotension with low-dose vasopressin in a patient receiving clozapine.Annie John, Clement Yeh, Jonathan Boyd, Philip E. Greilich
Journal of Cardiothoracic and Vascular Anesthesia. 2010-06-01 - 5 citationsMediastinal neoplasms in patients with Graves disease: a possible link between sustained hyperthyroidism and thymic neoplasia?Jonathan Dale Boyd, Ridas Juskevicius
Thyroid Research. 2012-07-23 - 4 citationsFine-Needle Aspiration is Superior to Needle Core Biopsy as a Sample Aquisition Method for Flow Cytometric Analysis in Suspected Hematologic Neoplasms.Jonathan Dale Boyd, George Drennan Smith, Heng Hong, Ronald Mageau, Ridas Juskevicius
Cytometry. Part B, Clinical Cytometry. 2014-08-23
Press Mentions
- Allen Fire Chief Participates in COVID-19 Vaccine TrialSeptember 8th, 2020